• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

降钙素受体刺激的前列腺癌细胞迁移由尿激酶受体-整合素信号传导介导。

Calcitonin receptor-stimulated migration of prostate cancer cells is mediated by urokinase receptor-integrin signaling.

作者信息

Thomas Shibu, Chiriva-Internati Maurizio, Shah Girish V

机构信息

Department of Pharmacology, University of Louisiana College of Pharmacy, Monroe, LA 71209, USA.

出版信息

Clin Exp Metastasis. 2007;24(5):363-77. doi: 10.1007/s10585-007-9073-y. Epub 2007 May 9.

DOI:10.1007/s10585-007-9073-y
PMID:17487556
Abstract

Abundance of calcitonin (CT) and calcitonin receptor (CTR) mRNA in primary prostate tumors positively correlates with tumor grade, and exogenously added CT increases the invasion of prostate cancer cell lines. We examined acute and chronic actions of CT on migration of highly metastatic PC-3M cells and poorly invasive LNCaP cells on several extracellular matrices in a spheroid disaggregation/migration assay. While PC-3M spheroids displayed maximum disaggregation/migration on vitronectin (VN), LNCaP spheroids preferred collagen but also migrated significantly on VN. Up-regulation of CT significantly enhanced disaggregation/migration of PC-3M spheroids on VN, but not on fibronectin. In contrast, down-regulation of CT, CTR, protein kinase A or urokinase-type plasminogen activator receptor (uPAR) led to amelioration of PC-3M spheroid disaggregation/migration. CT selectively increased surface activity of alpha v beta 3 or alpha 6 beta 5 integrins in PC-3M and LNCaP cell lines, respectively, and uPAR-integrin association. Finally, either CT or urokinase could completely restore migration of CT-knock-down PC-3M spheroids. But, only forced expression of urokinase receptor coupled with exogenous addition of urokinase restored migration of CTR-knock-down spheroids. These results support our hypothesis that up-regulation of CT biosynthesis and activation of CT-CTR axis in primary prostate tumors may have direct relevance in their progression to the metastatic phenotype.

摘要

原发性前列腺肿瘤中降钙素(CT)和降钙素受体(CTR)mRNA的丰度与肿瘤分级呈正相关,外源性添加CT可增加前列腺癌细胞系的侵袭能力。我们在球体解离/迁移试验中,研究了CT对高转移性PC-3M细胞和低侵袭性LNCaP细胞在几种细胞外基质上迁移的急性和慢性作用。虽然PC-3M球体在玻连蛋白(VN)上表现出最大程度的解离/迁移,但LNCaP球体更喜欢胶原蛋白,不过在VN上也有显著迁移。CT的上调显著增强了PC-3M球体在VN上的解离/迁移,但在纤连蛋白上没有。相反,CT、CTR、蛋白激酶A或尿激酶型纤溶酶原激活剂受体(uPAR)的下调导致PC-3M球体解离/迁移的改善。CT分别选择性地增加了PC-3M和LNCaP细胞系中αvβ3或α6β5整合素的表面活性,以及uPAR-整合素的结合。最后,CT或尿激酶都可以完全恢复CT敲低的PC-3M球体的迁移。但是,只有尿激酶受体的强制表达与外源性添加尿激酶相结合,才能恢复CTR敲低的球体的迁移。这些结果支持了我们的假设,即原发性前列腺肿瘤中CT生物合成的上调和CT-CTR轴的激活可能与其向转移表型的进展直接相关。

相似文献

1
Calcitonin receptor-stimulated migration of prostate cancer cells is mediated by urokinase receptor-integrin signaling.降钙素受体刺激的前列腺癌细胞迁移由尿激酶受体-整合素信号传导介导。
Clin Exp Metastasis. 2007;24(5):363-77. doi: 10.1007/s10585-007-9073-y. Epub 2007 May 9.
2
Calcitonin increases tumorigenicity of prostate cancer cells: evidence for the role of protein kinase A and urokinase-type plasminogen receptor.降钙素增加前列腺癌细胞的致瘤性:蛋白激酶A和尿激酶型纤溶酶原受体作用的证据
Mol Endocrinol. 2006 Aug;20(8):1894-911. doi: 10.1210/me.2005-0284. Epub 2006 Mar 30.
3
Knock-down of calcitonin receptor expression induces apoptosis and growth arrest of prostate cancer cells.降钙素受体表达的敲低诱导前列腺癌细胞凋亡和生长停滞。
Int J Oncol. 2007 Dec;31(6):1425-37.
4
Calcitonin increases invasiveness of prostate cancer cells: role for cyclic AMP-dependent protein kinase A in calcitonin action.降钙素增加前列腺癌细胞的侵袭性:环磷酸腺苷依赖性蛋白激酶A在降钙素作用中的作用。
Int J Cancer. 2005 Nov 20;117(4):551-60. doi: 10.1002/ijc.21158.
5
Calcitonin receptor increases invasion of prostate cancer cells by recruiting zonula occludens-1 and promoting PKA-mediated TJ disassembly.降钙素受体通过招募紧密连接蛋白-1并促进蛋白激酶A介导的紧密连接解体来增加前列腺癌细胞的侵袭能力。
Cell Signal. 2017 Aug;36:1-13. doi: 10.1016/j.cellsig.2017.04.008. Epub 2017 Apr 17.
6
Calcitonin stimulates the secretion of urokinase-type plasminogen activator from prostate cancer cells: its possible implications on tumor cell invasion.降钙素刺激前列腺癌细胞分泌尿激酶型纤溶酶原激活剂:其对肿瘤细胞侵袭的潜在影响。
Int J Cancer. 2006 Jun 1;118(11):2694-702. doi: 10.1002/ijc.21625.
7
Increased levels of urokinase plasminogen activator receptor in prostate cancer cells derived from repeated metastasis.源自反复转移的前列腺癌细胞中尿激酶型纤溶酶原激活物受体水平升高。
World J Urol. 2004 Apr;22(1):67-71. doi: 10.1007/s00345-003-0395-3. Epub 2004 Mar 30.
8
Urokinase-type plasminogen activator binding to its receptor stimulates tumor cell migration by enhancing integrin-mediated signal transduction.尿激酶型纤溶酶原激活剂与其受体结合,通过增强整合素介导的信号转导来刺激肿瘤细胞迁移。
Exp Cell Res. 1999 Jul 10;250(1):231-40. doi: 10.1006/excr.1999.4510.
9
Calcitonin promotes in vivo metastasis of prostate cancer cells by altering cell signaling, adhesion, and inflammatory pathways.降钙素通过改变细胞信号传导、黏附及炎症通路来促进前列腺癌细胞的体内转移。
Endocr Relat Cancer. 2008 Dec;15(4):953-64. doi: 10.1677/ERC-08-0136. Epub 2008 Sep 10.
10
Interleukin-1alpha enhances the aggressive behavior of pancreatic cancer cells by regulating the alpha6beta1-integrin and urokinase plasminogen activator receptor expression.白细胞介素-1α通过调节α6β1整合素和尿激酶型纤溶酶原激活剂受体的表达增强胰腺癌细胞的侵袭行为。
BMC Cell Biol. 2006 Feb 20;7:8. doi: 10.1186/1471-2121-7-8.

引用本文的文献

1
is essential for xenograft tumor development in mice injected with the human prostate cancer cell-line, LNCaP, and modulates cell migration and invasion.对于注射了人前列腺癌细胞系LNCaP的小鼠体内异种移植肿瘤的发展至关重要,并调节细胞迁移和侵袭。
J Mens Health. 2022 Feb;18(2). doi: 10.31083/jomh.2021.131. Epub 2021 Oct 14.
2
A-kinase anchoring protein 2 is required for calcitonin-mediated invasion of cancer cells.A激酶锚定蛋白2是降钙素介导的癌细胞侵袭所必需的。
Endocr Relat Cancer. 2016 Jan;23(1):1-14. doi: 10.1530/ERC-15-0425. Epub 2015 Oct 2.
3
Proteomic analysis of zoledronic-acid resistant prostate cancer cells unveils novel pathways characterizing an invasive phenotype.

本文引用的文献

1
Calcitonin increases tumorigenicity of prostate cancer cells: evidence for the role of protein kinase A and urokinase-type plasminogen receptor.降钙素增加前列腺癌细胞的致瘤性:蛋白激酶A和尿激酶型纤溶酶原受体作用的证据
Mol Endocrinol. 2006 Aug;20(8):1894-911. doi: 10.1210/me.2005-0284. Epub 2006 Mar 30.
2
Functional relevance of urinary-type plasminogen activator receptor-alpha3beta1 integrin association in proteinase regulatory pathways.尿激酶型纤溶酶原激活物受体-α3β1整合素在蛋白酶调节途径中的功能相关性
J Biol Chem. 2006 May 12;281(19):13021-13029. doi: 10.1074/jbc.M508526200. Epub 2006 Mar 1.
3
Calcitonin stimulates the secretion of urokinase-type plasminogen activator from prostate cancer cells: its possible implications on tumor cell invasion.
唑来膦酸耐药前列腺癌细胞的蛋白质组学分析揭示了具有侵袭性表型的新途径。
Oncotarget. 2015 Mar 10;6(7):5324-41. doi: 10.18632/oncotarget.2694.
4
RGD-Binding Integrins in Prostate Cancer: Expression Patterns and Therapeutic Prospects against Bone Metastasis.RGD 结合整合素在前列腺癌中的表达模式及其对骨转移的治疗前景。
Cancers (Basel). 2012 Oct 26;4(4):1106-45. doi: 10.3390/cancers4041106.
5
Urokinase-type plasminogen activator receptor (uPAR)-mediated regulation of WNT/β-catenin signaling is enhanced in irradiated medulloblastoma cells.尿激酶型纤溶酶原激活物受体(uPAR)介导的 WNT/β-连环蛋白信号转导在辐射照射的髓母细胞瘤细胞中增强。
J Biol Chem. 2012 Jun 8;287(24):20576-89. doi: 10.1074/jbc.M112.348888. Epub 2012 Apr 16.
6
Role of integrins in regulating proteases to mediate extracellular matrix remodeling.整合素在调节蛋白酶以介导细胞外基质重塑中的作用。
Cancer Microenviron. 2012 Dec;5(3):275-83. doi: 10.1007/s12307-012-0101-3. Epub 2012 Mar 22.
7
Identification of a small molecule class to enhance cell-cell adhesion and attenuate prostate tumor growth and metastasis.鉴定一类可增强细胞间黏附并减弱前列腺肿瘤生长和转移的小分子。
Mol Cancer Ther. 2009 Mar;8(3):509-20. doi: 10.1158/1535-7163.MCT-08-0693. Epub 2009 Mar 10.
8
Latrunculin A and its C-17-O-carbamates inhibit prostate tumor cell invasion and HIF-1 activation in breast tumor cells.拉春库林A及其C-17-O-氨基甲酸酯可抑制前列腺肿瘤细胞的侵袭以及乳腺肿瘤细胞中缺氧诱导因子-1(HIF-1)的激活。
J Nat Prod. 2008 Mar;71(3):396-402. doi: 10.1021/np070587w. Epub 2008 Feb 26.
降钙素刺激前列腺癌细胞分泌尿激酶型纤溶酶原激活剂:其对肿瘤细胞侵袭的潜在影响。
Int J Cancer. 2006 Jun 1;118(11):2694-702. doi: 10.1002/ijc.21625.
4
Calcitonin induces apoptosis resistance in prostate cancer cell lines against cytotoxic drugs via the Akt/survivin pathway.降钙素通过Akt/生存素途径诱导前列腺癌细胞系对细胞毒性药物产生凋亡抗性。
Cancer Biol Ther. 2005 Nov;4(11):1226-33. doi: 10.4161/cbt.4.11.2093. Epub 2005 Nov 5.
5
Calcitonin stimulates multiple stages of angiogenesis by directly acting on endothelial cells.降钙素通过直接作用于内皮细胞刺激血管生成的多个阶段。
Cancer Res. 2005 Sep 15;65(18):8519-29. doi: 10.1158/0008-5472.CAN-05-0848.
6
RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo.RNA干扰介导的尿激酶型纤溶酶原激活剂及尿激酶型纤溶酶原激活剂受体的敲低可抑制前列腺癌细胞的侵袭、存活及体内致瘤性。
J Biol Chem. 2005 Oct 28;280(43):36529-40. doi: 10.1074/jbc.M503111200. Epub 2005 Aug 26.
7
Calcitonin increases invasiveness of prostate cancer cells: role for cyclic AMP-dependent protein kinase A in calcitonin action.降钙素增加前列腺癌细胞的侵袭性:环磷酸腺苷依赖性蛋白激酶A在降钙素作用中的作用。
Int J Cancer. 2005 Nov 20;117(4):551-60. doi: 10.1002/ijc.21158.
8
Focal adhesion kinase is required for the spatial organization of the leading edge in migrating cells.粘着斑激酶是迁移细胞前沿空间组织所必需的。
J Cell Sci. 2005 Jun 15;118(Pt 12):2613-23. doi: 10.1242/jcs.02380. Epub 2005 May 24.
9
Focal adhesion kinase is required for bombesin-induced prostate cancer cell motility.胃泌素释放肽诱导前列腺癌细胞迁移需要粘着斑激酶。
Mol Cell Endocrinol. 2005 May 12;235(1-2):51-61. doi: 10.1016/j.mce.2004.06.014. Epub 2005 Mar 19.
10
Crystal structure of the human urokinase plasminogen activator receptor bound to an antagonist peptide.与拮抗剂肽结合的人尿激酶型纤溶酶原激活物受体的晶体结构
EMBO J. 2005 May 4;24(9):1655-63. doi: 10.1038/sj.emboj.7600635. Epub 2005 Apr 7.